| Place of Origin: | China |
|---|---|
| Brand Name: | BCB |
| Certification: | ISO |
| Model Number: | Liraglutid |
| Minimum Order Quantity: | 1 |
| Price: | 100 |
| Packaging Details: | 1kg/bag, 25kg/drum |
| Delivery Time: | 7 working days |
| Payment Terms: | L/C, D/A, D/P, T/T, , MoneyGram |
| Supply Ability: | 10000kg/month |
| Appearance: | White Powder | CAS No.: | 1118-68-9 |
|---|---|---|---|
| Shelf Life: | 24 Months | Storage: | Cool Dry Place |
| Purity: | 99% | MW: | 103.120 |
| MF: | C4H9NO2 |
API Pharmaceutical 98% Liraglutide Powder Diabetes control CAS 204656-20-2
| Product name | Liraglutide |
| Appearance | White powder |
| CAS | 204656-20-2 |
| MF | C4H9NO2 |
| Purity | 99% |
| Storage | Keep in cool dry place. |
The Introductction of Liraglutide :
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic GLP-1 that stimulates insu.lin secretion.
Marketed under the brand name Victoza,Liraglutide is an injectable developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing Liraglutide in the U.S. and E.U. under the brand name as a treatment for adults, who are obese or overweight with at least one weight-relatedcomorbid condition.
The Application & Function of Liraglutide :
Marketed under the brand name Victoza,Liraglutide is an injectable developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing Liraglutide in the U.S. and E.U. under the brand name as a treatment for adults, who are obese or overweight with at least one weight-relatedcomorbid condition.
1. Liraglutide acts in a glucose-dependent manner, meaning Liraglutide will stimulate insu.lin secretion only when blood glucose levels are higher than normal, preventing "overshoot".Consequently, Liraglutide shows negligible risk of hypoglycemia.
2. Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies).
3. Liraglutide decreases appetite and inhibits body weight gain,as shown in a head-to-head study versus glimepiride.
4. Liraglutide lowers blood triglyceride levels.
HNB Biotech company details